Ainos, Inc. (NASDAQ:AIMDW – Get Free Report) was the target of a significant decline in short interest during the month of October. As of October 30th, there was short interest totaling 8 shares, a decline of 95.8% from the October 15th total of 189 shares. Based on an average daily volume of 3,124 shares, the days-to-cover ratio is currently 0.0 days.
Ainos Price Performance
Shares of NASDAQ:AIMDW traded down $0.02 during trading on Tuesday, reaching $0.03. The company had a trading volume of 4,300 shares, compared to its average volume of 6,121. The company has a fifty day moving average of $0.06 and a two-hundred day moving average of $0.10. Ainos has a 12 month low of $0.03 and a 12 month high of $0.19.
Ainos Company Profile
Ainos, Inc. is a healthcare technology company developing diagnostic and therapeutic products. Its AI Nose platform uses artificial intelligence and sensors to analyze volatile organic compounds (VOCs), with the goal of supporting non-invasive screening and monitoring. The company is also developing point-of-care testing products. Ainos’s therapeutic work includes VELDONA, a low-dose oral interferon-alpha product candidate. The company was formerly known as Amarillo Biosciences and adopted the Ainos name in 2021.
Featured Stories
- Five stocks we like better than Ainos
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
